Current role
Drug Manufacturers - General · Healthcare
Chief Accounting Officer
2023-12-04–present
Dalton E. Smart III
Chief Accounting Officer
Merck & Co., Inc. (MRK)Equibles does not estimate personal net worth.
Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.
Get MRK alertsAbout Dalton E. Smart III
Dalton E. Smart III is recorded as Chief Accounting Officer at Merck & Co., Inc. (MRK) since December 4, 2023. Merck & Co., Inc. reported in an 8-K filed November 28, 2023 that Dalton E. Smart III was appointed Senior Vice President Finance – Global Controller, effective December 4, 2023. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Christine E. Seidman (Board Member) and 7 others.
“On November 28, 2023, the Board of Directors (the "Board") of the Company elected Dalton E. Smart III to serve as Senior Vice President Finance – Global Controller of the Company, effective December 4, 2023, making him the Company's principal accounting officer.”
Affiliation history
-
Current
2023-12-04–present
Company network
Leadership on record at Merck & Co., Inc.
- Robert M. Davis CEO, Chairman, Board Member
- Jennifer Zachary General Counsel
- Christine E. Seidman Board Member
- J.H. Noseworthy Board Member
- Kathy J. Warden Board Member
- P.B. Rothman Board Member
- P.J. Craig Board Member
- Paul J. Diaz Board Member
- R.B. Lazarus Board Member
- Stephen L. Mayo Board Member